Home/Filings/4/0001628280-24-049055
4//SEC Filing

Rosenbaum David P. 4

Accession 0001628280-24-049055

CIK 0001437402other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 6:34 PM ET

Size

7.5 KB

Accession

0001628280-24-049055

Insider Transaction Report

Form 4
Period: 2024-11-20
Rosenbaum David P.
SVP, Drug Development
Transactions
  • Sale

    Common Stock

    2024-11-20$4.79/sh4,941$23,690297,005 total
  • Sale

    Common Stock

    2024-11-20$4.79/sh2,243$10,754151,373 total(indirect: By Spouse)
Holdings
  • Common Stock

    (indirect: By Trust)
    77,592
Footnotes (3)
  • [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
  • [F2]The shares are directly held by the Reporting Person's wife.
  • [F3]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.

Issuer

ARDELYX, INC.

CIK 0001437402

Entity typeother

Related Parties

1
  • filerCIK 0001611311

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:34 PM ET
Size
7.5 KB